512 related articles for article (PubMed ID: 33716705)
1. Voltage-Gated Ca
Ortner NJ
Front Synaptic Neurosci; 2021; 13():636103. PubMed ID: 33716705
[TBL] [Abstract][Full Text] [Related]
2. Lower Affinity of Isradipine for L-Type Ca
Ortner NJ; Bock G; Dougalis A; Kharitonova M; Duda J; Hess S; Tuluc P; Pomberger T; Stefanova N; Pitterl F; Ciossek T; Oberacher H; Draheim HJ; Kloppenburg P; Liss B; Striessnig J
J Neurosci; 2017 Jul; 37(28):6761-6777. PubMed ID: 28592699
[TBL] [Abstract][Full Text] [Related]
3. Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice.
Poetschke C; Dragicevic E; Duda J; Benkert J; Dougalis A; DeZio R; Snutch TP; Striessnig J; Liss B
Sci Rep; 2015 Sep; 5():13688. PubMed ID: 26381090
[TBL] [Abstract][Full Text] [Related]
4. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
5. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
Duda J; Pötschke C; Liss B
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Brimblecombe KR; Connor-Robson N; Bataille CJR; Roberts BM; Gracie C; O'Connor B; Te Water Naude R; Karthik G; Russell AJ; Wade-Martins R; Cragg SJ
Eur J Neurosci; 2024 Mar; 59(6):1242-1259. PubMed ID: 37941514
[TBL] [Abstract][Full Text] [Related]
7. The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease.
Liss B; Striessnig J
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():263-289. PubMed ID: 30625283
[TBL] [Abstract][Full Text] [Related]
8. NCS-1 Deficiency Affects mRNA Levels of Genes Involved in Regulation of ATP Synthesis and Mitochondrial Stress in Highly Vulnerable
Simons C; Benkert J; Deuter N; Poetschke C; Pongs O; Schneider T; Duda J; Liss B
Front Mol Neurosci; 2019; 12():252. PubMed ID: 31827421
[TBL] [Abstract][Full Text] [Related]
9. Cav1.3 channel voltage dependence, not Ca2+ selectivity, drives pacemaker activity and amplifies bursts in nigral dopamine neurons.
Putzier I; Kullmann PH; Horn JP; Levitan ES
J Neurosci; 2009 Dec; 29(49):15414-9. PubMed ID: 20007466
[TBL] [Abstract][Full Text] [Related]
10. β2-subunit alternative splicing stabilizes Cav2.3 Ca
Siller A; Hofer NT; Tomagra G; Burkert N; Hess S; Benkert J; Gaifullina A; Spaich D; Duda J; Poetschke C; Vilusic K; Fritz EM; Schneider T; Kloppenburg P; Liss B; Carabelli V; Carbone E; Ortner NJ; Striessnig J
Elife; 2022 Jul; 11():. PubMed ID: 35792082
[TBL] [Abstract][Full Text] [Related]
11. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
Wang QM; Xu YY; Liu S; Ma ZG
Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
[TBL] [Abstract][Full Text] [Related]
12. Neuro-Restorative Effect of Nimodipine and Calcitriol in 1-Methyl 4-Phenyl 1,2,3,6 Tetrahydropyridine-Induced Zebrafish Parkinson's Disease Model.
Kim MJ; Cho SH; Seo Y; Kim SD; Park HC; Kim BJ
J Korean Neurosurg Soc; 2023 Dec; ():. PubMed ID: 38130142
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
[TBL] [Abstract][Full Text] [Related]
14. Potassium Channels in Parkinson's Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment.
Chen X; Feng Y; Quinn RJ; Pountney DL; Richardson DR; Mellick GD; Ma L
Pharmacol Rev; 2023 Jul; 75(4):758-788. PubMed ID: 36918260
[TBL] [Abstract][Full Text] [Related]
15. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
[TBL] [Abstract][Full Text] [Related]
16. The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease.
Ilijic E; Guzman JN; Surmeier DJ
Neurobiol Dis; 2011 Aug; 43(2):364-71. PubMed ID: 21515375
[TBL] [Abstract][Full Text] [Related]
17. Limited regulation of somatodendritic dopamine release by voltage-sensitive Ca channels contrasted with strong regulation of axonal dopamine release.
Chen BT; Moran KA; Avshalumov MV; Rice ME
J Neurochem; 2006 Feb; 96(3):645-55. PubMed ID: 16405515
[TBL] [Abstract][Full Text] [Related]
18. A concerted action of L- and T-type Ca(2+) channels regulates locus coeruleus pacemaking.
Matschke LA; Bertoune M; Roeper J; Snutch TP; Oertel WH; Rinné S; Decher N
Mol Cell Neurosci; 2015 Sep; 68():293-302. PubMed ID: 26319746
[TBL] [Abstract][Full Text] [Related]
19. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
Chan CS; Gertler TS; Surmeier DJ
Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
[TBL] [Abstract][Full Text] [Related]
20. Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons.
Philippart F; Destreel G; Merino-Sepúlveda P; Henny P; Engel D; Seutin V
J Neurosci; 2016 Jul; 36(27):7234-45. PubMed ID: 27383597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
